Taysha Gene Therapies Inc [NASDAQ: TSHA] plunged by -$0.01 during the normal trading session on while it closed the day at $2.78.
Taysha Gene Therapies Inc stock has also gained 6.72% of its value over the past 7 days. However, TSHA stock has inclined by 70.55% in the 3 months of the year. Over the past six months meanwhile, it has lost -7.33% and gained 60.69% year-on date.
The market cap for TSHA stock reached $727.05 million, with 205.05 million shares outstanding and 176.26 million shares in the current float. Compared to the average trading volume of 3.20M shares, TSHA reached a trading volume of 5920033 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Taysha Gene Therapies Inc [TSHA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TSHA shares is $7.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TSHA stock is a recommendation set at 1.09. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BMO Capital Markets have made an estimate for Taysha Gene Therapies Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 27, 2024. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on April 09, 2024, representing the official price target for Taysha Gene Therapies Inc stock. Previously, the target price had yet another drop from $14 to $1.50, while Jefferies kept a Hold rating on TSHA stock. On January 27, 2023, analysts decreased their price target for TSHA shares from 23 to 3.
The Average True Range (ATR) for Taysha Gene Therapies Inc is set at 0.25, with the Price to Sales ratio for TSHA stock in the period of the last 12 months amounting to 100.70. The Price to Book ratio for the last quarter was 10.35, with the Price to Cash per share for the same quarter was set at 0.45.
TSHA stock trade performance evaluation
Taysha Gene Therapies Inc [TSHA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.72. With this latest performance, TSHA shares gained by 7.75% in over the last four-week period, additionally sinking by -7.33% over the last 6 months – not to mention a drop of -11.18% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TSHA stock in for the last two-week period is set at 61.93, with the RSI for the last a single of trading hit 60.99, and the three-weeks RSI is set at 61.78 for Taysha Gene Therapies Inc [TSHA]. The present Moving Average for the last 50 days of trading for this stock 1.98, while it was recorded at 2.69 for the last single week of trading, and 1.95 for the last 200 days.
Taysha Gene Therapies Inc [TSHA]: An insightful look at the core fundamentals
Taysha Gene Therapies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.35 and a Current Ratio set at 5.35.
Earnings per share (EPS) analysis for Taysha Gene Therapies Inc [TSHA] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TSHA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Taysha Gene Therapies Inc go to 11.90%.
Taysha Gene Therapies Inc [TSHA]: Institutional Ownership
The top three institutional holders of TSHA stocks are: FMR LLC with ownership of 21.21 million shares, which is approximately 9.1103%. RTW INVESTMENTS, LP, holding 18.8 million shares of the stock with an approximate value of $$42.11 million in TSHA stocks shares; and RTW INVESTMENTS, LP, currently with $$41.78 million in TSHA stock with ownership which is approximately 8.0104%.
